Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2019 |
| Author/s |
author: E. Sally Ward David J Kuter Marie Godar Hans de Haard |
| Publication date | December 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |